Intermittent administration of senolytics holds the opportunity to lessen the risk of patients developing adverse ailments, lower off-goal outcomes of medication and prevent progress of drug resistance of senescent cells, which don't divide, a characteristic that sets them other than most cancers cells, as cancer cells commonly get beneficial mutations https://geraldm888eqa1.wikidank.com/user